welcome
research groups
genetic services
job opportunities
seminars
contact us
   

The main interest of our group is study colorectal (CRC) and testicular germ cell tumors (TGCT) focusing in three main objectives: a) Genes involved in the development and progression of both type of tumors; b) Mechanisms of resistance to chemotherapy treatment with 5-FU (5-fluorouracil) in CRC, and cisplatin (CDDP) in non-seminomatous TGCT; c) Study of Prognostic factors in colorectal tumors. This research is developed in a multidisciplinary team shaped by biologist, oncologist, surgeons, and pathologist.

Our experimental approach combines the use of human primary tumor series, and animal models, basically nude mice and the nematode Caenorhabditis elegans (C.elegans). In the last three years, we have developed in nude mice a model for the study of non-seminomatous germ cell tumors after orthopical (in the testis) implantation of primary TGCT, as well a library of colorectal (CRC-X) and hepatic metastases (HM-X) xenografts in nude mice after subcutaneous implantation. We are also using the small nematode C. elegans as a model system to study the mechanisms of resistance to 5-FU. Despite of its simplicity, C. elegans is a multicellular organism that shares many fundamental genetic programs with humans. Therefore, many results obtained in the C. elegans system are likely to be applicable to colorectal tumors.

Current projects:

Identification of a tumor suppressor gene/s located in the short arm of chromosome 4, in the region 4p14-16 in colorectal and hepatic metastasis.
Tumor biology and mechanisms of resistance to cisplatin treatment in testicular germ cell tumors.
Prognostic factors in colorectal tumors and hepatic metastases.
Identification of resistance genes to 5-FU treatment using the nematode C. elegans as a model organism.